nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—PTGFR—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.00337	0.117	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00207	0.0716	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00158	0.0545	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00126	0.0434	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.00121	0.042	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00114	0.0392	CbGpPWpGaD
Travoprost—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00109	0.00113	CcSEcCtD
Travoprost—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00109	0.00112	CcSEcCtD
Travoprost—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00109	0.00112	CcSEcCtD
Travoprost—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.00109	0.00112	CcSEcCtD
Travoprost—Cough—Delavirdine—acquired immunodeficiency syndrome	0.00108	0.00112	CcSEcCtD
Travoprost—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.00108	0.00111	CcSEcCtD
Travoprost—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00108	0.00111	CcSEcCtD
Travoprost—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.00108	0.00111	CcSEcCtD
Travoprost—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00108	0.00111	CcSEcCtD
Travoprost—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00107	0.00111	CcSEcCtD
Travoprost—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00107	0.0011	CcSEcCtD
Travoprost—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.00107	0.0011	CcSEcCtD
Travoprost—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.00107	0.0011	CcSEcCtD
Travoprost—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.00106	0.00109	CcSEcCtD
Travoprost—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00106	0.00109	CcSEcCtD
Travoprost—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.00106	0.00109	CcSEcCtD
Travoprost—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00106	0.00109	CcSEcCtD
Travoprost—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.00106	0.00109	CcSEcCtD
Travoprost—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00105	0.00109	CcSEcCtD
Travoprost—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.00105	0.00108	CcSEcCtD
Travoprost—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00104	0.00108	CcSEcCtD
Travoprost—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00104	0.00107	CcSEcCtD
Travoprost—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00104	0.00107	CcSEcCtD
Travoprost—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00104	0.00107	CcSEcCtD
Travoprost—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00104	0.00107	CcSEcCtD
Travoprost—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.00107	CcSEcCtD
Travoprost—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00103	0.00106	CcSEcCtD
Travoprost—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00103	0.00106	CcSEcCtD
Travoprost—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.00103	0.00106	CcSEcCtD
Travoprost—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.00103	0.00106	CcSEcCtD
Travoprost—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00103	0.00106	CcSEcCtD
Travoprost—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00103	0.00106	CcSEcCtD
Travoprost—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00103	0.00106	CcSEcCtD
Travoprost—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00103	0.00106	CcSEcCtD
Travoprost—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.00106	CcSEcCtD
Travoprost—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00102	0.00106	CcSEcCtD
Travoprost—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00102	0.00105	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.00102	0.00105	CcSEcCtD
Travoprost—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.00102	0.00105	CcSEcCtD
Travoprost—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00102	0.00105	CcSEcCtD
Travoprost—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.00101	0.00104	CcSEcCtD
Travoprost—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00104	CcSEcCtD
Travoprost—Rash—Didanosine—acquired immunodeficiency syndrome	0.00101	0.00104	CcSEcCtD
Travoprost—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00104	CcSEcCtD
Travoprost—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00101	0.00104	CcSEcCtD
Travoprost—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00101	0.00104	CcSEcCtD
Travoprost—Cough—Ritonavir—acquired immunodeficiency syndrome	0.001	0.00103	CcSEcCtD
Travoprost—Headache—Didanosine—acquired immunodeficiency syndrome	0.001	0.00103	CcSEcCtD
Travoprost—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000999	0.00103	CcSEcCtD
Travoprost—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000998	0.00103	CcSEcCtD
Travoprost—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000996	0.00103	CcSEcCtD
Travoprost—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000995	0.00102	CcSEcCtD
Travoprost—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000993	0.00102	CcSEcCtD
Travoprost—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000993	0.00102	CcSEcCtD
Travoprost—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000991	0.00102	CcSEcCtD
Travoprost—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000989	0.00102	CcSEcCtD
Travoprost—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000986	0.00102	CcSEcCtD
Travoprost—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000985	0.00101	CcSEcCtD
Travoprost—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000984	0.00101	CcSEcCtD
Travoprost—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000984	0.00101	CcSEcCtD
Travoprost—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000982	0.00101	CcSEcCtD
Travoprost—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000981	0.00101	CcSEcCtD
Travoprost—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00098	0.00101	CcSEcCtD
Travoprost—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000978	0.00101	CcSEcCtD
Travoprost—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000977	0.00101	CcSEcCtD
Travoprost—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000977	0.00101	CcSEcCtD
Travoprost—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000977	0.00101	CcSEcCtD
Travoprost—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000974	0.001	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000971	0.000999	CcSEcCtD
Travoprost—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000968	0.000996	CcSEcCtD
Travoprost—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000966	0.000995	CcSEcCtD
Travoprost—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000966	0.000995	CcSEcCtD
Travoprost—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000966	0.000994	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000965	0.000993	CcSEcCtD
Travoprost—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000964	0.000993	CcSEcCtD
Travoprost—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000958	0.000987	CcSEcCtD
Travoprost—Pain—Indinavir—acquired immunodeficiency syndrome	0.000958	0.000987	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000956	0.033	CbGpPWpGaD
Travoprost—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000956	0.000984	CcSEcCtD
Travoprost—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000954	0.000982	CcSEcCtD
Travoprost—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000953	0.000981	CcSEcCtD
Travoprost—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000952	0.00098	CcSEcCtD
Travoprost—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000951	0.000979	CcSEcCtD
Travoprost—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000949	0.000977	CcSEcCtD
Travoprost—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000949	0.000977	CcSEcCtD
Travoprost—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000947	0.000975	CcSEcCtD
Travoprost—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000947	0.000975	CcSEcCtD
Travoprost—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000944	0.000972	CcSEcCtD
Travoprost—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000941	0.000969	CcSEcCtD
Travoprost—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000941	0.000969	CcSEcCtD
Travoprost—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000941	0.000969	CcSEcCtD
Travoprost—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000937	0.000965	CcSEcCtD
Travoprost—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000937	0.000965	CcSEcCtD
Travoprost—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000934	0.000962	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000934	0.000962	CcSEcCtD
Travoprost—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000932	0.00096	CcSEcCtD
Travoprost—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000929	0.000957	CcSEcCtD
Travoprost—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000924	0.000951	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000923	0.000951	CcSEcCtD
Travoprost—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00092	0.000947	CcSEcCtD
Travoprost—Cough—Lamivudine—acquired immunodeficiency syndrome	0.00092	0.000947	CcSEcCtD
Travoprost—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00092	0.000947	CcSEcCtD
Travoprost—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000919	0.000946	CcSEcCtD
Travoprost—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000917	0.000944	CcSEcCtD
Travoprost—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000916	0.000944	CcSEcCtD
Travoprost—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000914	0.000942	CcSEcCtD
Travoprost—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000914	0.000941	CcSEcCtD
Travoprost—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000913	0.00094	CcSEcCtD
Travoprost—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00091	0.000937	CcSEcCtD
Travoprost—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000905	0.000932	CcSEcCtD
Travoprost—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000905	0.000932	CcSEcCtD
Travoprost—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000905	0.000932	CcSEcCtD
Travoprost—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000905	0.000932	CcSEcCtD
Travoprost—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000903	0.00093	CcSEcCtD
Travoprost—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000903	0.00093	CcSEcCtD
Travoprost—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000902	0.000929	CcSEcCtD
Travoprost—Headache—Nevirapine—acquired immunodeficiency syndrome	0.0009	0.000926	CcSEcCtD
Travoprost—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000897	0.000924	CcSEcCtD
Travoprost—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000897	0.000924	CcSEcCtD
Travoprost—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000897	0.000924	CcSEcCtD
Travoprost—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000896	0.000923	CcSEcCtD
Travoprost—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000894	0.000921	CcSEcCtD
Travoprost—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000892	0.000918	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000891	0.000918	CcSEcCtD
Travoprost—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000887	0.000913	CcSEcCtD
Travoprost—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000886	0.000912	CcSEcCtD
Travoprost—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000884	0.000911	CcSEcCtD
Travoprost—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000878	0.000904	CcSEcCtD
Travoprost—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000877	0.000903	CcSEcCtD
Travoprost—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000876	0.000902	CcSEcCtD
Travoprost—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000876	0.000902	CcSEcCtD
Travoprost—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000875	0.000902	CcSEcCtD
Travoprost—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000875	0.000901	CcSEcCtD
Travoprost—Rash—Stavudine—acquired immunodeficiency syndrome	0.000874	0.0009	CcSEcCtD
Travoprost—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000873	0.000899	CcSEcCtD
Travoprost—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000873	0.000899	CcSEcCtD
Travoprost—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000873	0.000899	CcSEcCtD
Travoprost—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000871	0.000897	CcSEcCtD
Travoprost—Headache—Stavudine—acquired immunodeficiency syndrome	0.000869	0.000894	CcSEcCtD
Travoprost—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000866	0.000892	CcSEcCtD
Travoprost—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000866	0.000892	CcSEcCtD
Travoprost—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000866	0.000892	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000865	0.0299	CbGpPWpGaD
Travoprost—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000865	0.00089	CcSEcCtD
Travoprost—Rash—Abacavir—acquired immunodeficiency syndrome	0.000861	0.000887	CcSEcCtD
Travoprost—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00086	0.000886	CcSEcCtD
Travoprost—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00086	0.000886	CcSEcCtD
Travoprost—Headache—Abacavir—acquired immunodeficiency syndrome	0.000856	0.000881	CcSEcCtD
Travoprost—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000855	0.00088	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000854	0.000879	CcSEcCtD
Travoprost—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000853	0.000878	CcSEcCtD
Travoprost—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000853	0.000878	CcSEcCtD
Travoprost—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000844	0.000869	CcSEcCtD
Travoprost—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000843	0.000868	CcSEcCtD
Travoprost—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000837	0.000862	CcSEcCtD
Travoprost—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000836	0.00086	CcSEcCtD
Travoprost—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000835	0.00086	CcSEcCtD
Travoprost—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000835	0.00086	CcSEcCtD
Travoprost—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000828	0.000853	CcSEcCtD
Travoprost—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000826	0.000851	CcSEcCtD
Travoprost—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000826	0.00085	CcSEcCtD
Travoprost—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000825	0.000849	CcSEcCtD
Travoprost—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000824	0.000849	CcSEcCtD
Travoprost—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000824	0.000848	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000822	0.000846	CcSEcCtD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000819	0.0283	CbGpPWpGaD
Travoprost—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000811	0.000835	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00081	0.028	CbGpPWpGaD
Travoprost—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000809	0.000833	CcSEcCtD
Travoprost—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000808	0.000832	CcSEcCtD
Travoprost—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000804	0.000828	CcSEcCtD
Travoprost—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000804	0.000828	CcSEcCtD
Travoprost—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000804	0.000828	CcSEcCtD
Travoprost—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000801	0.000825	CcSEcCtD
Travoprost—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000801	0.000825	CcSEcCtD
Travoprost—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000801	0.000825	CcSEcCtD
Travoprost—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000797	0.000821	CcSEcCtD
Travoprost—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000794	0.000817	CcSEcCtD
Travoprost—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000793	0.000817	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000784	0.000807	CcSEcCtD
Travoprost—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00078	0.000803	CcSEcCtD
Travoprost—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000778	0.000802	CcSEcCtD
Travoprost—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000777	0.000801	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000776	0.0268	CbGpPWpGaD
Travoprost—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000772	0.000795	CcSEcCtD
Travoprost—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000771	0.000794	CcSEcCtD
Travoprost—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000771	0.000794	CcSEcCtD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00077	0.0266	CbGpPWpGaD
Travoprost—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000767	0.00079	CcSEcCtD
Travoprost—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000767	0.00079	CcSEcCtD
Travoprost—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000766	0.000789	CcSEcCtD
Travoprost—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00076	0.000782	CcSEcCtD
Travoprost—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00076	0.000782	CcSEcCtD
Travoprost—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000759	0.000782	CcSEcCtD
Travoprost—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000757	0.00078	CcSEcCtD
Travoprost—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000755	0.000777	CcSEcCtD
Travoprost—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000749	0.000771	CcSEcCtD
Travoprost—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000746	0.000769	CcSEcCtD
Travoprost—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000743	0.000765	CcSEcCtD
Travoprost—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000743	0.000765	CcSEcCtD
Travoprost—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000742	0.000764	CcSEcCtD
Travoprost—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000741	0.000763	CcSEcCtD
Travoprost—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000741	0.000763	CcSEcCtD
Travoprost—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000737	0.000759	CcSEcCtD
Travoprost—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000736	0.000758	CcSEcCtD
Travoprost—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000736	0.000758	CcSEcCtD
Travoprost—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000727	0.000749	CcSEcCtD
Travoprost—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000724	0.000746	CcSEcCtD
Travoprost—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000717	0.000738	CcSEcCtD
Travoprost—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000716	0.000737	CcSEcCtD
Travoprost—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000713	0.000734	CcSEcCtD
Travoprost—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000709	0.00073	CcSEcCtD
Travoprost—Rash—Indinavir—acquired immunodeficiency syndrome	0.000707	0.000728	CcSEcCtD
Travoprost—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000706	0.000727	CcSEcCtD
Travoprost—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000703	0.000724	CcSEcCtD
Travoprost—Headache—Indinavir—acquired immunodeficiency syndrome	0.000702	0.000723	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000702	0.0242	CbGpPWpGaD
Travoprost—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.0007	0.000721	CcSEcCtD
Travoprost—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000693	0.000714	CcSEcCtD
Travoprost—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00069	0.000711	CcSEcCtD
Travoprost—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00068	0.0007	CcSEcCtD
Travoprost—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000672	0.000692	CcSEcCtD
Travoprost—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00067	0.00069	CcSEcCtD
Travoprost—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000668	0.000688	CcSEcCtD
Travoprost—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000667	0.000687	CcSEcCtD
Travoprost—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000666	0.000686	CcSEcCtD
Travoprost—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000664	0.000684	CcSEcCtD
Travoprost—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000663	0.000683	CcSEcCtD
Travoprost—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000663	0.000683	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00066	0.0228	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00066	0.0228	CbGpPWpGaD
Travoprost—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000647	0.000666	CcSEcCtD
Travoprost—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000641	0.00066	CcSEcCtD
Travoprost—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000639	0.000658	CcSEcCtD
Travoprost—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000638	0.000657	CcSEcCtD
Travoprost—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000638	0.000657	CcSEcCtD
Travoprost—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000635	0.000654	CcSEcCtD
Travoprost—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000634	0.000653	CcSEcCtD
Travoprost—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000629	0.000648	CcSEcCtD
Travoprost—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00062	0.000638	CcSEcCtD
Travoprost—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000617	0.000636	CcSEcCtD
Travoprost—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000617	0.000635	CcSEcCtD
Travoprost—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000609	0.000627	CcSEcCtD
Travoprost—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000602	0.00062	CcSEcCtD
Travoprost—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000596	0.000614	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000591	0.0204	CbGpPWpGaD
Travoprost—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000591	0.000608	CcSEcCtD
Travoprost—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00059	0.000608	CcSEcCtD
Travoprost—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000589	0.000606	CcSEcCtD
Travoprost—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000587	0.000604	CcSEcCtD
Travoprost—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000569	0.000586	CcSEcCtD
Travoprost—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000569	0.000585	CcSEcCtD
Travoprost—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000568	0.000585	CcSEcCtD
Travoprost—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000565	0.000582	CcSEcCtD
Travoprost—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000556	0.000573	CcSEcCtD
Travoprost—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000542	0.000559	CcSEcCtD
Travoprost—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000542	0.000558	CcSEcCtD
Travoprost—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000539	0.000555	CcSEcCtD
Travoprost—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000536	0.000552	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000534	0.0185	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000528	0.0182	CbGpPWpGaD
Travoprost—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000511	0.000526	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000502	0.0174	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000502	0.0174	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000502	0.0173	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000491	0.017	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000478	0.0165	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000452	0.0156	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000444	0.0153	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000382	0.0132	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000344	0.0119	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000303	0.0105	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000302	0.0104	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00029	0.01	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00029	0.01	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000284	0.00981	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000284	0.00981	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000274	0.00947	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000262	0.00906	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000258	0.0089	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000258	0.0089	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000216	0.00746	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000213	0.00735	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000207	0.00716	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000196	0.00677	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000195	0.00672	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000193	0.00667	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000179	0.00619	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000177	0.0061	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000162	0.0056	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000152	0.00526	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000152	0.00526	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000116	0.004	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000114	0.00394	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000112	0.00388	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000104	0.00361	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000102	0.00353	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.03e-05	0.00208	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6e-05	0.00207	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.54e-05	0.00122	CbGpPWpGaD
